Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Tuesday, September 3, 2019
7 hours ago - Following a court win late last month to keep one such drug substance out of the hands of compounders, the US Food and Drug Administration (FDA) pointed to
09/03/2019 | 08/28/2019 | Stemell Inc | Office of Biological Products Operations - Division II | Deviations/CFR/Regulations for Human Cells, Tissues & Cellular Products (HCT/Ps) |
09/03/2019 | 08/26/2019 | Absonutrix, LLC | Division of Human and Animal Food Operations East III | Dietary Supplement/Adulterated |
09/03/2019 | 08/23/2019 | Sportron International, Inc. | Office of Human and Animal Food West Division 3 | Unapproved New Drugs/Misbranded |
09/03/2019 | 08/22/2019 | Polimeros y Servicios S.A. | Center for Drug Evaluation and Research | CGMP/Finished Pharmaceuticals/Adulterated/Unapproved/Misbranded |
09/03/2019 | 08/19/2019 | Haw Par Healthcare Limited | Center for Drug Evaluation and Research | CGMP/Finished Pharmaceuticals/Adulterated/Misbranded |
09/03/2019 | 08/16/2019 | Metuchen Pharmaceuticals, LLC. | Center for Drug Evaluation and Research | False & Misleading Claims/Misbranded |
09/03/2019 | 08/12/2019 | Yino, Inc. | Center for Drug Evaluation and Research | CGMP/Active Pharmaceutical Ingredient (API)/Adulterated |
Subscribe to:
Posts (Atom)